Posted on January 15, 2008 by Trevor Butterworth
Trevor Butterworth
Ok. Think. How might cars be dangerous? For starters, you can crash them and kill or maim yourself and others through careless driving or being drunk at the wheel. In fact, let’s stop there, as automotive crashes have accounted for roughly 38,000 deaths each year for the past 10 years. And that’s just the [...]
Filed under: New Car Smell, Plastic, Statistical Analysis, Toxic Chemicals, phthalates, risk analysis | Tagged: Fire Retardants, Jeroen Buters, Men's Health, MSNBC, The Ecology Center, VOCs | No Comments »
Posted on January 8, 2008 by Trevor Butterworth
Rebecca Goldin Ph.D
Last week, The National Journal launched a scathing attack on the way casualties in Iraq were estimated by authors Gilbert Burnham, Riyadh Lafta, Shannon Doocy, and Les Roberts in a report published by Lancet in 2006. Many conservative pundits had already put their wits to the test trying to find ways to discredit [...]
Filed under: Statistical Analysis | Tagged: deaths, Iraq war, Lancet, National Journal | 2 Comments »
Posted on November 13, 2007 by Trevor Butterworth
Trevor Butterworth, Huffington Post
One of the World Cancer Research Fund’s key recommendations on how to avoid cancer may be flawed because of what was not included in the survey …more
Originally published October 31, 2007
Filed under: Cancer, Colon Cancer, Diet, STATS on Huffington Post, Statistical Analysis | Tagged: , Harvard School of Public Health, Walter Willett | No Comments »
Posted on November 13, 2007 by Trevor Butterworth
The Chicago Tribune seems to have put moderate drinking in the doghouse. According to its a recent news story, “comprehensive reviews of the scientific evidence” have found people are at risk for cancer, even if they drink moderately. The point of the article seems to be a cost/benefit analysis. Do the known benefits of moderate [...]
Filed under: Alcohol, Risk, Statistical Analysis | Tagged: heavy drinking, moderate drinking | No Comments »
Posted on November 13, 2007 by Trevor Butterworth
Rebecca Goldin Ph.D
A recent flurry of interest in the benefits of breastfeeding has led to some rather scary messages from the press: if you don’t nurse — or if you don’t nurse enough — your baby will have all sorts of problems, from obesity to leukemia. Parents are being told point blank: formula kills. A [...]
Filed under: Breast Feeding, Diabetes, Nursing, Risk, Statistical Analysis, Uncategorized | Tagged: Department of Health and Human Services | No Comments »
Posted on November 11, 2007 by Trevor Butterworth
Trevor Butterworth
The current issue of Biocentury, a trade publication that covers the pharmaceutical industry, should be essential and chastening reading for the journalists, editors and politicians who helped turn a limited, problematic study on the risks of the diabetes drug rosliglitazone (brand name Avandia) into a major international health scare.
In a comprehensive report on the [...]
Filed under: Avandia, Diabetes, Endocrinology, Food and Drug Administration, Meta Analysis, Statistical Analysis | Tagged: Annals of Internal Medicine, Biocentury, David Graham, HbA1c, Medstar Research Institute, New England Journal of Medicine, Steve Nissen, Steve Usdin | 1 Comment »
Posted on November 9, 2007 by Trevor Butterworth
Trevor Butterworth and Jenna Krall
Sometimes it’s the actual set and not what you’re watching that’s dangerous to your health… more
Originally published July 17, 2007
Filed under: Consumer Product Safety Commission, NEISS, Statistical Analysis, Television, What's my risk, risk analysis | Tagged: number of fatal accidents, number of nonfatal accidents, odds of dying, odds of injury | No Comments »
Posted on November 9, 2007 by Trevor Butterworth
Trevor Butterworth
From Wired: Why would the FDA allow a pharmaceutical company to continue to sell an apparently dangerous drug? The answer is not simple, and at a time when mistrust of the government’s relationship with the healthcare industry seems to be increasing, the subtleties can get lost in daily news reports… more
Originally published August 2, [...]
Filed under: Avandia, Diabetes, Drugs, Food and Drug Administration, Statistical Analysis, risk analysis | Tagged: heart attack, Wired | No Comments »
Posted on November 9, 2007 by Trevor Butterworth
Trevor Butterworth
A Food and Drug Administration advisory panel recommended in a 22 to 1 to one vote that the diabetes drug Avandia remain on the market, with additional warnings about cardiac risk, but not the most extreme drug warning – a black box – in the FDA arsenal.
The recommendation, which is non-binding but almost certain [...]
Filed under: Avandia, Diabetes, Drugs, Endocrinology, Food and Drug Administration, Statistical Analysis | Tagged: David Graham, Glaxo Smith Kline, New England Journal of Medicine, New York Times, Steve Nissen | No Comments »
Posted on November 9, 2007 by Trevor Butterworth
Trevor Butterworth
The line between the New York Times editorial page, which has been highly critical of the FDA’s handling of the potential risk from the diabetes drug Avandia, and the health news pages appears to have disappeared in the Times’ coverage of the forthcoming FDA hearings on the drug… more
Originally published July 27, 2007
Filed under: Avandia, Diabetes, Endocrinology, Food and Drug Administration, Meta Analysis, Statistical Analysis | Tagged: , Bruce Psaty, Nature Clinical Practice, New England Journal of Medicine, New York Times, Steve Nissen, The Lancet | No Comments »